Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma?
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (2) , 427-433
- https://doi.org/10.1016/j.ygyno.2006.12.027
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- FDG-PET for management of cervical and ovarian cancerGynecologic Oncology, 2005
- Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical–pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trialGynecologic Oncology, 2005
- Histopathologic parameters of prognosis in cervical cancer - a reviewInternational Journal of Gynecologic Cancer, 2004
- Controversies in the Radiotherapeutic Management of Cervical CancerJournal of Clinical Oncology, 2003
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI Journal of the National Cancer Institute, 2002
- ChemoradiotherapyDrugs, 2000
- Optimizing radiation parameters for cervical cancerSeminars in Radiation Oncology, 2000
- Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysisJAMA, 1997
- Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysisRadiotherapy and Oncology, 1995
- Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vaginaSeminars in Surgical Oncology, 1994